MTAP and lymphoma: Meanwhile, the Institut de Recherches Internationales Servier is conducting a Phase I study to establish the maximum tolerated dose (MTD) of AG-270, either alone or in combination with taxane-based chemotherapy, in individuals with advanced solid tumors or lymphoma exhibiting homozygous deletion of methylthioadenosine phosphorylase (MTAP) [33].